Non-adherence to drug therapy and drug acquisition costs in a national population - a patient-based register study

Table 2 Drug acquisition costs related to non-adherence with varying therapies and ages in Sweden in 2006.

Age -Therapy	DDD		Acq. Cost		Rate of	Cost of	Rate of	Acq. Cost related to NA
	*million	%	million SEK	%	PNA	prescribe drugs	SNA	million SEK	% of Acq cost
All	5253	100	23154	100	3	23870	50	11219	48, 5
Therapy:
Continuing	3927	74, 8	13798	59, 6	3	14225	50	6686	48, 5
short-term	1326	25, 2	8659	37, 4	3	8927	30	2410	27, 8
(no DDD)			697	3, 0	3	718	30	194	27, 8
Total	5253	100	23154	100, 0		23870		9290	40, 1
Age:
0-19	241	4, 6	1641	7, 1	2	1675	50	804	49, 0
20-49	976	18, 6	5966	25, 8	4	6215	50	2859	47, 9
50-69	1894	36, 1	8568	37, 0	3	8833	50	4151	48, 5
70-	2142	40, 8	6979	30, 1	2	7122	50	3418	49, 0
Total	5253	100	23154	100, 0		239844	50	11232	48, 5
Therapy and age
Continuing
0-19	179		651	2, 8	2	664	50	319	49, 0
20-49	696		3542	15, 3	4	3689	50	1697	47, 9
50-69	1407		5267	22, 7	3	5430	50	2552	48, 5
70-	1645		4339	18, 7	2	4428	50	2125	49, 0
Short-term
0-19	63		937	4, 0	2	956	30	268	28, 6
20-49	279		2233	9, 6	4	2326	30	605	27, 1
50-69	487		2989	12, 9	3	3081	30	832	27, 8
70-	497		2501	10, 8	2	2552	30	715	28, 6
no DDD
0-19			53	0, 2	2	54	30	15	28, 6
20-49			192	0, 8	4	200	30	52	27, 1
50-69			313	1, 3	3	322	30	87	27, 8
70-			139	0, 6	2	142	30	40	28, 6
Total	5253	0	23154	100, 0		23844		9306	40, 2

DDD, acquisition costs for dispensed drug (Acq cost), rate of primary non-adherence (PNA), estimated acquisition costs for prescribed drugs, rate of secondary non-adherence (SNA) and drug acquisition costs related to non-adherence (NA) for individuals with varying therapies and ages in Sweden in 2006.

ISSN: 1472-6963